You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday.
A familiar blood testing pitch
I trekked across the Bay to Palo Alto to get an inside look at how a prominent genetics and big data expert is trying to overhaul blood testing. For about six years, Stanford professor Mike Snyder and his lab have been refining a method for collecting individual drops of blood and analyzing their molecules for health indicators. (Throughout one week in 2019, he drew 98 drops of his own blood to test the process, dragging a dry-ice filled cooler with him to each meeting.)
This article is exclusive to STAT+ subscribers
Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.
Already have an account? Log in
Already have an account? Log in
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect